Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06923462 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

VoiceLove: An App-Based COMMunication Tool Designed to Address DeliriUm and Improve Family ENgagement and PatIent/Family SatisfaCtion in CriticAlly Ill PaTiEnts (COMMUNICATE)

Study acronym: COMMUNICATE
StatusRecruiting
PhaseNot applicable
Started2025-08-06
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from Vanderbilt University Medical Center

Amendment history

2026-09-08
Study Status, Outcome Measures v6
Primary endpoint(s) modified1 entry, revised
WasAssess engagement among patients during acute hospitalization
NowTo assess communication and engagement among patients and family members during hospitalization. The primary feasibility outcome is app engagement among participants randomized to the intervention arm.
2025-08-26
Study Status, Contacts/Locations v5
Study sitescontacts updated at 1 of 1 site
2025-08-06
Not Yet Recruiting→Recruiting Study Status, Oversight, Contacts/Locations v4
Trial statusNot Yet Recruiting→Recruiting
Start date2025-07-30→2025-08-06
Study sites0→1
2025-07-28
Study Status, Oversight v3
Start date2025-06-30→2025-07-30
2025-06-02
Study Status, Oversight v2
Start date2025-05-15→2025-06-30
2025-05-08
Study Status, Oversight v1
Start date2025-04-15→2025-05-15
2025-04-03
Original filing
VoiceLove is a phone application allowing family and patients to share information in a secure platform. This project will compare the VoiceLove app to usual care to learn about whether VoiceLove improves patient-family communication, family engagement, and ICU delirium.
Trial Details
NCT Number NCT06923462
Lead Sponsor Vanderbilt University Medical Center
Conditions Critical Illness, Intensive Care Medicine
Enrollment 100 participants
Start Date 2025-08-06
Primary Completion 2027-03-15 (estimated)
Study Completion 2028-03-15 (estimated)
Updated on ClinicalTrials.gov 2026-09-11